Conduct of phase I trials in children with cancer.
Malcolm A. Smith(National Cancer Institute), Teresa J. Vietti, Richard S. Ungerleider(Theradex Oncology (United States)), Nita L. Seibel(Children's of Alabama), J D Borsi, Gilles Vassal(Université Paris-Saclay), Mark L. Bernstein(Centre Hospitalier Universitaire Sainte-Justine), W. Archie Bleyer(Oregon Health & Science University), F Pein, Riccardo Riccardi(Università Cattolica del Sacro Cuore), A D Pearson, P. S. P. Ho, I J Lewis, Gregory H. Reaman(National Cancer Institute), C B Pratt, Robert C. Trueworthy
Cited by 93
Related Papers
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724